Bryant David Lim Prelude Therapeutics Inc (PRLD) insider trading activity

PRLD Quotes by TradingView

Bryant David Lim is CLO, Interim CFO, Corp Sec. of Prelude Therapeutics Inc. Currently has a direct ownership of 2,400 shares of PRLD, which is worth approximately $5,088. The most recent transaction as insider was on May 24, 2023, when has been sold 2,400 shares (Common Stock) at a price of $5.39 per share, resulting in proceeds of $12,936. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.4K
0% 3M change
0% 12M change
Total Value Held $5,088

Bryant David Lim Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2023
BUY
Open market or private purchase
$12,936 $5.39 p/Share
2,400 Added 50.0%
2,400 Common Stock

Also insider at

IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
SVP AND GENERAL COUNSEL
BDL

Bryant David Lim

CLO, Interim CFO, Corp Sec.
Exton, PA

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if

News

Receive news related to Prelude Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRLD